Oslo Cancer Cluster invites you to the symposium “Prostate Cancer’s Precision Promise”. Prostate Cancer is the most common cancer to effect men. The clumps of cancerous cells on the walnut-shaped prostate are slow to grow and are prone to spread to form a more aggressive deadly version. In this symposium, you will hear about the advances in the promise of precision cancer medicine that will be able to pair interdisciplinary data to provide better and more efficient treatment for cancer.
This symposium includes a networking session focusing on Horizon 2020 funding opportunities for both academia and industry in the field of cancer and personalised medicine.
This event is FREE to attend. Please register by completing the form at the end of this page.
This symposium is supported by:
|09:00–09:15||Registration and Light Refreshments|
|09:15–09:30||Welcome and Introduction|
|09:30–10:10||Extracellular Vesicles as Biomarkers and Disease Mediators: A Case for Multi-omics in Prostate Cancer Precision Medicine
Prof. Michelle Hill, QIMR Berghofer Medical Research Institute, The University of Queensland, Australia
|10:10–10:50||The Value of Quantitative Proteomics for Precision Medicine in Prostate Cancer
Prof. Diego Iglesias-Gato, University of Copenhagen, Denmark
|11:10–11:50||Molecular Tests to Improve Precision Medicine in Prostate Cancer
Prof. Kristin Austlid Taskén, Oslo University Hospital, Norway
|11:50–12:30||The National Prostate Cancer Registry: Results, Available Data for Research and Future Direction
Dr. Tom Børge Johannesen, Cancer Registry of Norway, Norway
Horizon 2020 – Cancer and Personalised Medicine
Dr. Gupta Udatha, Oslo Cancer Cluster, Norway
|13:00–13:30||Logistics Innovation in Cancer Medicine
Mr. Raphael Grill, Kuehne+Nagel, Norway